Professional Documents
Culture Documents
Drug Study Ambroxol
Drug Study Ambroxol
Drug Study Ambroxol
Medication (include
dosage, route &
frequency)
Ambroxol
0.5 TID
Drug Classification
Indication
Mucolytic
Adjuvant therapy in
patients with abnormal,
viscid, or in spissated
mucous secretions in
acute and chronic
bronchopulmonary
diseases, and in
pulmonary
complications of cystic
fibrosis and surgery,
tracheostomy, and
atelectasis.
Mechanism of
Action
Side effects/Adverse
Reactions
Occasional
gastrointestinal side
effects may occur but
these are almost
invariably mild.
Nursing
Responsibilities
Monitor S/Sx of
aspiration of
excess secretions
and for
bronchospasm .
Monitor ABGs,
pulmonary
functions and
pulse oximetry
as indicated.
Have suction
apparatus
immediately
available.
Report difficulty
with clearing the
airway or any
other respiratory
distress.
Contraindications
and Cautions
There is no absolute
contraindication but in
patients with gastric
ulceration relative
caution should be
observed.